Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise Transcript
Source: SeekingAlpha
2026-03-24 16:24:51 ET
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise March 24, 2026 9:30 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise Transcript
Alnylam Pharmaceuticals Inc.
NASDAQ: ALNY
ALNY Trading
4.83% G/L:
$303.94 Last:
529,633 Volume:
$297.22 Open:
ALNY Latest News
June 03, 2026 04:45:00 pm
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
ALNY Stock Data
$42,146,950,218
131,611,785
0.16%
379
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
